Silencing of the PP2A catalytic subunit causes HER-2/neu positive breast cancer cells to undergo apoptosis

Experimental Cell Research

Volumn 316, Issue 20, 2010, Pages 3387-3396

  Wong, Lee Lee ^a   Zhang, Daohai ^b   Chang, Chan Fong ^a   Koay, Evelyn S C ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Apoptosis; Caspase 3; HER 2 neu; P38 MAPK; Phosphorylation; PP2A

Indexed keywords

CASPASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOPROTEIN PHOSPHATASE 2A;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER THERAPY; CATALYSIS; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVE SITE; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; TUMOR GROWTH;

EID: 78149406959     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.06.007     Document Type: Article

References (40)

1. Shi Y. Serine/threonine phosphatases: mechanism through structure. Cell 2009, 139(3):468-484.
2. Schönthal A.H. Role of serine/threonine protein phosphatase 2A in cancer. Cancer Lett. 2001, 170(1):1-13.
3. Chen J., Martin B.L., Brautigan D.L. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 1992, 257(5074):1261-1264.
4. Chen J., Parsons S., Brautigan D.L. Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. J. Biol. Chem. 1994, 269(11):7957-7962.
5. Brautigan D.L. Flicking the switches: phosphorylation of serine/threonine protein phosphatases. Semin. Cancer Biol. 1995, 6(4):211-217.
6. Longin S., Zwaenepoel K., Louis J.V., Dilworth S., Goris J., Janssens V. Selection of protein phosphatase 2A regulatory subunits is mediated by the C terminus of the catalytic Subunit. J. Biol. Chem. 2007, 282(37):26971-26980.
7. Young M.R.I., Kolesiak K., Meisinger J. Protein phosphatase-2A regulates endothelial cell motility and both the phosphorylation and the stability of focal adhesion complexes. Int. J. Cancer 2002, 100(3):276-282.
8. Young M.R.I., Liu S.W., Meisinger J. Protein phosphatase-2A restricts migration of Lewis lung carcinoma cells by modulating the phosphorylation of focal adhesion proteins. Int. J. Cancer 2003, 103(1):38-44.
9. Xu L., Deng X. Suppression of cancer cell migration and invasion by protein phosphatase 2A through dephosphorylation of mu- and m-calpains. J. Biol. Chem. 2006, 281(46):35567-35575.
10. Pullar C.E., Chen J., Isseroff R.R. PP2A activation by β2-adrenergic receptor agonists: novel regulatory mechanism of keratinocyte migration. J. Biol. Chem. 2003, 278(25):22555-22562.
11. Liu R., Zhou X.W., Tanila H., Bjorkdahl C., Wang J.Z., Guan Z.Z., Cao Y., Gustafsson J.A., Winblad B., Pei J.J. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology. J. Cell. Mol. Med. 2008, 12(1):241-257.
12. Qian W., Shi J., Yin X., Iqbal K., Grundke-Iqbal I., Gong C.X., Liu F. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta. J. Alzheimers Dis. 2010, 19(4):1221-1229.
13. Ruediger R., Pham H.T., Walter G. Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene. Oncogene 2001, 20(1):10-15.
14. Calin G.A., di Iasio M.G., Caprini E., Vorechovsky I., Natali P.G., Sozzi G., Croce C.M., Barbanti-Brodano G., Russo G., Negrini M. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene 2000, 19(9):1191-1195.
15. Dupont W.D., Breyer J.P., Bradley K.M., Schuyler P.A., Plummer W.D., Sanders M.E., Page D.L., Smith J.R. Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk. Cancer 2010, 116(1):8-19.
16. Rubin I., Yarden Y. The basic biology of HER2. Ann. Oncol. 2001, 12(Suppl 1):S3-S8.
17. Warren C.M., Landgraf R. Signaling through ERBB receptors: multiple layers of diversity and control. Cell. Signal. 2006, 18(7):923-933.
18. Arias-Romero L.E., Saha S., Villamar-Cruz O., Yip S.C., Ethier S.P., Zhang Z.Y., Chernoff J. Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells. Cancer Res. 2009, 69(11):4582-4588.
19. Julien S.G., Dubé N., Read M., Penney J., Paquet M., Han Y., Kennedy B.P., Muller W.J., Tremblay M.L. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat. Genet. 2007, 39(3):338-346.
20. Bentires-Alj M., Neel B.G. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. Cancer Res. 2007, 67(6):2420-2424.
21. Shimizu S., Ugi S., Maegawa H., Egawa K., Nishio Y., Yoshizaki T., Shi K., Nagai Y., Morino K., Nemoto K., Nakamura T., Bryer-Ash M., Kashiwagi A. Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J. Biol. Chem. 2003, 278(44):43095-43101.
22. Shi K., Ugi S., Shimizu S., Sekine O., Ikeda K., Egawa K., Yoshizaki T., Nagai Y., Nishio Y., Takada T., Torii R., Kimura H., Kashiwagi A., Maegawa H. Membrane localization of protein-tyrosine phosphatase 1B is essential for its activation of sterol regulatory element-binding protein-1 gene expression. Biochem. Biophys. Res. Commun. 2007, 363(3):626-632.
23. Ugi S., Shi K., Nishio Y., Shimizu S., Guo B., Sekine O., Ikeda K., Egawa K., Yoshizaki T., Nagai Y., Koya D., Takada T., Torii R., Kimura H., Kashiwagi A., Maegawa H. Membrane localization of protein-tyrosine phosphatase 1B is essential for its activation of sterol regulatory element-binding protein-1 gene expression and consequent hypertriglyceridaemia. J. Biochem. 2009, 146(4):541-547.
24. Wong L.L., Chang C.F., Koay E.S.C., Zhang D. Tyrosine phosphorylation of PP2A is regulated by HER-2 signalling and correlates with breast cancer progression. Int. J. Oncol. 2009, 34(5):1291-1301.
25. Tanaka Y., Gavrielides M.V., Mitsuuchi Y., Fujii T., Kazanietz M.G. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J. Biol. Chem. 2003, 278(36):33753-33762.
26. Aburai N., Yoshida M., Ohnishi M., Kimura K.I. Sanguinarine as a potent and specific inhibitor of protein phosphatase 2C in vitro and induces apoptosis via phosphorylation of p38 in HL60 cells. Biosci. Biotechnol. Biochem. 2010, 74(3):548-552.
27. Segreto H.R.C., Oshima C.T.F., Franco M.F., Silva M.R.R., Egami M.I., Teixeira V.P.C., Segreto R.A. Phosphorylation and cytoplasmic localization of MAPK p38 during apoptosis signaling in bone marrow granulocytes of mice irradiated in vivo and the role of amifostine in reducing these effects. Acta Histochem. 2010, Epub ahead of print. 10.1016/j.acthis.2009.12.002.
28. Davoli A., Hocevar B.A., Brown T.L. Progression and treatment of HER2-positive breast cancer. Cancer Chemother. Pharmacol. 2010, 65(4):611-623.
29. Brown-Shimer S., Johnson K.A., Hill D.E., Bruskin A.M. Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. Cancer Res. 1992, 52(2):478-482.
30. Zhai Y.F., Beittenmiller H., Wang B., Gould M.N., Oakley C., Esselman W.J., et al. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res. 1993, 53(10 Suppl):2272-2278.
31. Wiener J.R., Kerns B.J., Harvey E.L., Conaway M.R., Iglehart J.D., Berchuck A., Bast R.C. Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression. J. Natl. Cancer Inst. 1994, 86(5):372-378.
32. Götz J., Probst A., Ehler E., Hemmings B., Kues W. Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(21):12370-12375.
33. Li X., Scuderi A., Letsou A., Virshup D.M. B56-associated protein phosphatase 2A is required for survival and protects from apoptosis in Drosophila melanogaster. Mol. Cell. Biol. 2002, 22(11):3674-3684.
34. He X., Anderson J.C., del Pozo O., Gu Y.Q., Tang X., Martin G.B. Silencing of subfamily I of protein phosphatase 2A catalytic subunits results in activation of plant defense responses and localized cell death. Plant J. 2004, 38(4):563-577.
35. Alvarado-Kristensson M., Andersson T. Protein phosphatase 2A regulates apoptosis in neutrophils by dephosphorylating both p38 MAPK and its substrate caspase 3. J. Biol. Chem. 2005, 280(7):6238-6244.
36. Boudreau R.T.M., Conrad D.M., Hoskin D.W. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase. Cell. Signal. 2007, 19(1):139-151.
37. Cairns J., Qin S., Philp R., Tan Y.H., Guy G.R. Dephosphorylation of the small heat shock protein Hsp27 in vivo by protein phosphatase 2A. J. Biol. Chem. 1994, 269(12):9176-9183.
38. Zhang D., Wong L.L., Koay E.S.C. Phosphorylation of Ser78 of Hsp27 correlated with HER-2/neu status and lymph node positivity in breast cancer. Mol. Cancer 2007, 6:52.
39. Strack S., Cribbs J.T., Gomez L. Critical role for protein phosphatase 2A heterotrimers in mammalian cell survival. J. Biol. Chem. 2004, 279(46):47732-47739.
40. Kong M., Fox C.J., Mu J., Solt L., Xu A., Cinalli R.M., Birnbaum M.J., Lindsten T. l. The PP2A-associated protein alpha4 is an essential inhibitor of apoptosis. Science 2004, 306(5696):695-698.